PEDBASE.org - The Pediatric Database -
Detailed information of HEPATOCELLULAR CARCINOMA
HEPATOCELLULAR CARCINOMA
DEFINITION:
A malignant tumor of the liver characterized by a mass in the
right upper quadrant.
EPIDEMIOLOGY:
- incidence: ?
- age of onset:
- median: 9-10 years; two peaks: <4 years and between 12-15
years
- risk factors:
PATHOGENESIS:
- also called hepatoma
- in childhood, hepatocellular carcinomas are associated with
essentially all types of cirrhosis, (i.e., cirrhosis due to
malnutrition, biliary atresia, giant cell hepatitis, etc.)
- HBsAg acquried through perinatal transmission may result in
the development of a hepatocellular carcinoma by 10 years of age
2. Conditions Predisposing to Hepatoma
- Hepatitis B & C
- Neonatal Hepatitis
- Biliary Atresia
- Intrahepatic Cholestasis
2. Metabolic
- Tyrosinemia-I
- Von Gierke Disease
- Alpha-1-Antitrypsin Deficiency
3. Drugs
- Methotrexate
- Androgenic Anabolic Steroids (Fanconi Anemia)
4. Others
- Ataxia Telangiectasia
- Neurofibromatosis
CLINICAL FEATURES:
- abdominal mass +/- distension
- abdominal pain
- hepatomegaly/splenomegaly
- anorexia and weight loss
- jaundice or fever (in 15-20%)
- hemoperitoneum due to tumor rupture (in 5%)
2. Metastases
- lung
- bone marrow
- regional lymph nodes
INVESTIGATIONS:
- tumor invasive, usually multicentric and bile stained
- large well differentiated tumor cells, broad trabeculae,
tumor giant cells, nucleolar prominence
- a fibrolamellar subgroup
2. Imaging Studies
1. Abdominal Ultrasound/CT/MRI
2. Chest X-Ray/CT/MRI
3. Serum
- CBC - mild anemia, thrombocytosis (in 10%)
- LFT - elevated AST, ALT, LDH, alkaline phosphatase
- serum alpha-fetoprotein level may be elevated (but not to
the same degree as in HEPATOCELLULAR CARCINOMA)
4. Bone Marrow
MANAGEMEMT:
1. Surgery
1. Lobectomy
- right and left partial and complete lobectomy and
trisegmentectomy
2. Liver Transplantation
2. Chemotherapy
1. Adjuvent Therapy
- used pre and post resection
- can reduce the size of the primary tumor and metastases
- doxorubicin and cisplatin
3. Prognosis
- 5 year survival 13% (only with tumors which have been
totally resected)
|
Pediatric Database - HEPATOCELLULAR CARCINOMA
Pediatric Organization - Pedbase [at] Gmail.com